You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
|
|---|---|
| Published in |
Journal of Hematology & Oncology, July 2020
|
| DOI | 10.1186/s13045-020-00924-z |
| Pubmed ID | |
| Authors |
Yonghan He, Sajid Khan, Zhiguang Huo, Dongwen Lv, Xuan Zhang, Xingui Liu, Yaxia Yuan, Robert Hromas, Mingjiang Xu, Guangrong Zheng, Daohong Zhou |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 22% |
| Canada | 1 | 11% |
| France | 1 | 11% |
| Unknown | 5 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 56% |
| Scientists | 4 | 44% |
Mendeley readers
The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 137 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 17 | 12% |
| Student > Ph. D. Student | 15 | 11% |
| Student > Master | 11 | 8% |
| Student > Doctoral Student | 9 | 7% |
| Student > Bachelor | 9 | 7% |
| Other | 18 | 13% |
| Unknown | 58 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 28 | 20% |
| Chemistry | 14 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 9% |
| Medicine and Dentistry | 7 | 5% |
| Agricultural and Biological Sciences | 4 | 3% |
| Other | 10 | 7% |
| Unknown | 62 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 December 2022.
All research outputs
#3,641,119
of 23,292,144 outputs
Outputs from Journal of Hematology & Oncology
#282
of 1,209 outputs
Outputs of similar age
#89,821
of 399,295 outputs
Outputs of similar age from Journal of Hematology & Oncology
#14
of 37 outputs
Altmetric has tracked 23,292,144 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,209 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,295 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.